부산대학교 도서관

Tournilhac O; Institute for Medical Informatics, Statistics, and Epidemiology, University Leipzig, Leipzig, Germany.; Altmann B; Institute for Medical Informatics, Statistics, and Epidemiology, University Leipzig, Leipzig, Germany.; Friedrichs B; Department of Medicine A, University Hospital Muenster, Muenster, Germany.; Bouabdallah K; Service d'Hématologie Clinique et de Thérapie Cellulaire, CHU Bordeaux, Bordeaux, France.; Leclerc M; Service d'Hématologie Clinique, Hôpital Henri Mondor, Hôpitaux de Paris, Créteil, France.; Cartron G; Departement Hématologie Clinique, CHU de Montpellier, Montpellier, France.; Turlure P; Service d'Hématologie Clinique, CHU Dupuytren, Limoges, France.; Reimer P; Department of Hematology, Oncology and Stem Cell Transplantation, Evang. Kliniken Essen-Mitte, Essen, Germany.; Wagner-Drouet E; University Medicine III Mainz, Mainz, Germany.; Sanhes L; Service d'Hématologie Clinique, CH Saint-Jean, Perpignan, France.; Houot R; Hematology Department, Rennes University Hospital, INSERM Research Unit 1236, Rennes, France.; Roussel M; Service d'Hématologie Clinique, CHU Dupuytren, Limoges, France.; Service d'Hématologie, IUCT-Oncopole, Toulouse, France.; Kroschinsky F; Medizinische Klinik I, University Hospital Dresden, Dresden, Germany.; Dreger P; Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Viardot A; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.; de Leval L; Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.; Rosenwald A; Department of Pathology, University of Wuerzburg and Comprehensive Cancer Center Mainfranken, Wuerzburg, Germany.; Gaulard P; Department of Pathology, University Hospital Henri Mondor, University Paris-Est Créteil, Inserm U955, Créteil, France.; Wulf G; Department of Hematology and Oncology, Georg August University, Goettingen, Germany.; Villate A; Service d'Hématologie et Thérapie Cellulaire, CHU de Tours, Tours, France.; Latiere C; Institute for Medical Informatics, Statistics, and Epidemiology, University Leipzig, Leipzig, Germany.; Elmaagacli A; Department of Hematology and Stem Cell Transplantation, Asklepios-Klinik St Georg, Hamburg, Germany.; Glass B; Department of Hematology and Stem Cell Transplantation, Helios Klinikum Berlin-Buch, Berlin, Germany.; Poeschel V; Department of Internal Medicine 1, Saarland University Medical School, Homburg/Saar, Germany.; Damaj G; Hematology Institute, University Hospital, Normandy University, Caen, France.; Sibon D; Department of Hematology, Necker University Hospital, University-Sorbonne Paris Cite, Paris, France.; Durot E; Service d'Hématologie Clinique, Centre Hospitalier Universitaire, Hopital Robert Debré, Reims, France.; Bilger K; Hematology Department, CHU, Strasbourg, France.; Banos A; Department of Hematology, Centre Hospitalier de la Cote de Basque, Bayonne, France.; Haenel M; Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Chemnitz, Germany.; Dreyling M; Department of Medicine III, Ludwig-Maximilians-University, Muenchen, Germany.; Keller U; Clinic and Policlinic for Internal Medicine III, School of Medicine, Technical University Munich, Munich, Germany.; Tiab M; Centre Hospitalier Départemental, La Roche Sur Yon, France.; Drenou B; Service d'Hématologie Clinique GHRMSA, Mulhouse, France.; Cornillon J; Service d'Hématologie et thérapie cellulaire, CHU de Saint Etienne, France.; Nguyen S; Clinical Hematology Unit, Groupe Hospitalier Pitié-Salpêtrière, APHP, Paris, France.; Robin M; Institut d'Hématologie, Hospital Saint Louis Paris, APHP, Paris, France.; Nickelsen M; Onkologie Lerchenfeld, Hamburg, Germany.; Trümper L; Department of Hematology and Oncology, Georg August University, Goettingen, Germany.; Lenz G; Department of Medicine A, University Hospital Muenster, Muenster, Germany.; Ziepert M; Institute for Medical Informatics, Statistics, and Epidemiology, University Leipzig, Leipzig, Germany.; Schmitz N; Department of Medicine A, University Hospital Muenster, Muenster, Germany.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Morschhauser F; Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France. franck.morschhauser@chu-lille.fr.; Dahiya S; Stanford University School of Medicine, Stanford, CA, USA.; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Palomba ML; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Martin Garcia-Sancho A; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.; Reguera Ortega JL; Hospital Virgen del Rocío, Instituto de Biomedicina de la Universidad de Sevilla, Seville, Spain.; Kuruvilla J; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Jäger U; Medical University of Vienna, Vienna, Austria.; Cartron G; Montpellier University Hospital Center, UMR CNRS 5535, Montpellier, France.; Izutsu K; National Cancer Center Hospital, Tokyo, Japan.; Dreyling M; LMU University Hospital, München, Germany.; Kahl B; Washington University School of Medicine in St. Louis, St. Louis, MO, USA.; Ghesquieres H; Hôpital Lyon Sud, Lyon, France.; Ardeshna K; University College London Hospitals Biomedical Research Centre, London, UK.; Goto H; Hokkaido University Hospital, Sapporo, Japan.; Barbui AM; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Abramson JS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Borchmann P; Universität zu Köln, Köln, Germany.; Fleury I; Hôpital Maisonneuve - Rosemont, Montreal, Quebec, Canada.; Mielke S; Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, Stockholm, Sweden.; Skarbnik A; Novant Health Cancer Institute, Charlotte, NC, USA.; de Vos S; UCLA Santa Monica Medical Centre, Santa Monica, CA, USA.; Kamdar M; University of Colorado Cancer Center, Aurora, CO, USA.; Karmali R; Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.; Viardot A; Department of Internal Medicine III, University Hospital, Ulm, Germany.; Farazi T; Bristol Myers Squibb, Brisbane, CA, USA.; Fasan O; Bristol Myers Squibb, Princeton, NJ, USA.; Lymp J; Bristol Myers Squibb, Seattle, WA, USA.; Vedal M; Bristol Myers Squibb, Seattle, WA, USA.; Nishii R; Bristol Myers Squibb, Princeton, NJ, USA.; Avilion A; Bristol Myers Squibb, Seattle, WA, USA.; Papuga J; Bristol Myers Squibb, Boudry, Switzerland.; Kumar J; Bristol Myers Squibb, Princeton, NJ, USA.; Nastoupil LJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE

Morschhauser F; Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France. franck.morschhauser@chu-lille.fr.; Dahiya S; Stanford University School of Medicine, Stanford, CA, USA.; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Palomba ML; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Martin Garcia-Sancho A; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.; Reguera Ortega JL; Hospital Virgen del Rocío, Instituto de Biomedicina de la Universidad de Sevilla, Seville, Spain.; Kuruvilla J; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Jäger U; Medical University of Vienna, Vienna, Austria.; Cartron G; Montpellier University Hospital Center, UMR CNRS 5535, Montpellier, France.; Izutsu K; National Cancer Center Hospital, Tokyo, Japan.; Dreyling M; LMU University Hospital, München, Germany.; Kahl B; Washington University School of Medicine in St. Louis, St. Louis, MO, USA.; Ghesquieres H; Hôpital Lyon Sud, Lyon, France.; Ardeshna K; University College London Hospitals Biomedical Research Centre, London, UK.; Goto H; Hokkaido University Hospital, Sapporo, Japan.; Barbui AM; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Abramson JS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Borchmann P; Universität zu Köln, Köln, Germany.; Fleury I; Hôpital Maisonneuve - Rosemont, Montreal, Quebec, Canada.; Mielke S; Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, Stockholm, Sweden.; Skarbnik A; Novant Health Cancer Institute, Charlotte, NC, USA.; de Vos S; UCLA Santa Monica Medical Centre, Santa Monica, CA, USA.; Kamdar M; University of Colorado Cancer Center, Aurora, CO, USA.; Karmali R; Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.; Viardot A; Department of Internal Medicine III, University Hospital, Ulm, Germany.; Farazi T; Bristol Myers Squibb, Brisbane, CA, USA.; Fasan O; Bristol Myers Squibb, Princeton, NJ, USA.; Lymp J; Bristol Myers Squibb, Seattle, WA, USA.; Vedal M; Bristol Myers Squibb, Seattle, WA, USA.; Nishii R; Bristol Myers Squibb, Princeton, NJ, USA.; Avilion A; Bristol Myers Squibb, Seattle, WA, USA.; Papuga J; Bristol Myers Squibb, Boudry, Switzerland.; Kumar J; Bristol Myers Squibb, Princeton, NJ, USA.; Nastoupil LJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Borchmann P; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany. Electronic address: peter.borchmann@uk-koeln.de.; Ferdinandus J; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany.; Schneider G; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany.; Moccia A; Swiss Group for Clinical Cancer Research, Bern, Switzerland; Oncology Institute of Southern Switzerland, EOC, Medical Oncology, Bellinzona, Switzerland.; Greil R; 3rd Medical Department, Paracelcus Medical University, Salzburg, Austria; Salzburg Cancer Research Institute, Cancer Cluster Salzburg, Salzburg, Austria; Arbeitsgemeinschaft Medikamentöse Tumortherapie, Salzburg, Austria.; Hertzberg M; Prince of Wales Hospital Department of Haematology and University NSW, Sydney, NSW, Australia; Australasian Leukaemia & Lymphoma Group, Melbourne, VIC, Australia.; Schaub V; University of Tübingen, Tübingen, Germany.; Hüttmann A; Department of Haematology, University Hospital, University Duisburg-Essen, Essen, Germany.; Keil F; Department of Haematology, Hanusch Krankenhaus, Vienna, Austria.; Dierlamm J; University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Hänel M; Department III of Internal Medicine, Klinikum Chemnitz, Chemnitz, Germany.; Novak U; Swiss Group for Clinical Cancer Research, Bern, Switzerland; Department of Medical Oncology, University Hospital Bern, Bern, Switzerland.; Meissner J; Department of Hematology and Oncology, University of Heidelberg, Heidelberg, Germany.; Zimmermann A; Department of Hematology and Oncology, Klinikum Leverkusen, Leverkusen, Germany.; Mathas S; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Berlin, Germany; Humboldt University of Berlin, Berlin Institute of Health, Berlin, Germany; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Biology of Malignant Lymphomas, Berlin, Germany; Experimental and Clinical Research Center (ECRC), a joint cooperation between Charité and MDC, Berlin, Germany.; Zijlstra JM; Department of Hematology, Amsterdam UMC, Vrije Universiteit, Cancer Center, Amsterdam, Netherlands.; Fosså A; Department of Oncology, Oslo University Hospital, Oslo, Norway; Nordic Lymphoma Group, University Hospital of Ulm, Ulm, Germany.; Viardot A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.; Hertenstein B; Department of Internal Medicine I, Klinikum Bremen Mitte, Bremen, Germany.; Martin S; Department of Haematology and Oncology, Robert Bosch Hospital, Stuttgart, Germany.; Giri P; Department of Haematology and Bone Marrow Transplant, Royal-Adelaide-Hospital, Adelaide, SA, Australia.; Scholl S; Klinik für Innere Medizin II, Jena University Hospital, Jena, Germany.; Topp MS; Department of Internal Medicine II, Hematology and Oncology, University Hospital Wuerzburg, Wuerzburg, Germany.; Jung W; Department of Haematology and Oncology, Göttingen, Germany.; Vucinic V; Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Germany.; Beck HJ; Department of Medicine III, Universitätsmedizin Mainz, Mainz, Germany.; Kerkhoff A; Department for Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Muenster, Muenster, Germany.; Unger B; Hämatologie, Onkologie und Tumorimmunologie, HELIOS Klinikum Berlin-Buch, Berlin, Germany.; Rank A; Department of Internal Medicine II, University Hospital Augsburg, Augsburg, Germany.; Schroers R; Department of Hematology and Oncology, Universitätsklinikum Knappschaftskrankenhaus Bochum, Ruhr-University Bochum, Germany.; Zum Büschenfelde CM; Clinic for Hematology, Oncology, Immunology and Palliative Medicine, Vincentius-Deaconry Clinics gAG, Karslruhe, Germany.; de Wit M; Clinic for Hematology, Oncology and Palliative Medicine, Vivantes Klinikum Neukölln, Berlin, Germany.; Trautmann-Grill K; Medical Clinic I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.; Kamper P; Nordic Lymphoma Group, University Hospital of Ulm, Ulm, Germany; Department of Hematology, University Hospital of Aarhus, Aarhus, Denmark.; Molin D; Nordic Lymphoma Group, University Hospital of Ulm, Ulm, Germany; Department of Immunology, Genetics and Pathology, Cancer Immunotherapy, Uppsala University, Uppsala, Sweden.; Kreissl S; Ordensklinikum Linz Elisabethinen, Linz, Austria.; Kaul H; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany.; von Tresckow B; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany; Department of Haematology, University Hospital, University Duisburg-Essen, Essen, Germany.; Borchmann S; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany.; Behringer K; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany.; Fuchs M; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany.; Rosenwald A; Institute for Pathology, University Hospital Würzburg, Würzburg, Germany.; Klapper W; Karl Lennert Cancer Center, University Hospital Schleswig-Holstein, Kiel, Germany.; Eich HT; Department of Radiotherapy, University Hospital of Muenster, Muenster, Germany.; Baues C; Department of Radiation Oncology, University Hospital of Ruhr-Universität Bochum, Marien Hospital Herne, Herne, Germany.; Zomas A; Global Medical Lead for Lymphoma & Leukemia at Takeda Oncology, Cambridge, MA, USA.; Hallek M; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany.; Dietlein M; Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany.; Kobe C; Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany.; Diehl V; Faculty of Medicine, University of Cologne, Cologne, Germany; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital, Düsseldorf, Germany; German Hodgkin Study Group, Cologne, Germany.

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Burmeister T; Department of Hematology, Oncology and Tumor Immunology, CVK, Charité-Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. thomas.burmeister@charite.de.; Ströh AS; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Kehden B; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Trautmann H; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Meyer C; Diagnostic Center of Acute Leukemia (DCAL), Institute of Pharmaceutical Biology, Goethe University, Frankfurt, Germany.; Marschalek R; Diagnostic Center of Acute Leukemia (DCAL), Institute of Pharmaceutical Biology, Goethe University, Frankfurt, Germany.; Larghero P; Diagnostic Center of Acute Leukemia (DCAL), Institute of Pharmaceutical Biology, Goethe University, Frankfurt, Germany.; Schwartz S; Department of Hematology, Oncology and Tumor Immunology, CBF, Charité Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Steffen B; Department of Medicine II, Goethe University, University Hospital, Frankfurt, Germany.; Spriewald B; University Hospital Erlangen, Department of Internal Medicine 5, Hematology and Oncology, Erlangen, Germany.; Heinicke T; Department of Hematology and Oncology, Otto-von-Guericke University Hospital, Magdeburg, Germany.; Jäkel N; Department of Hematology, Oncology, University Hospital, Halle/Saale, Germany.; Westermann J; Department of Hematology, Oncology and Tumor Immunology, CVK, Charité-Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Nachtkamp K; Department of Hematology, Oncology, University Hospital of Düsseldorf, Düsseldorf, Germany.; Viardot A; Department of Hematology, Oncology, University Hospital Ulm, Ulm, Germany.; Topp MS; Department of Hematology, Oncology, University Hospital Würzburg, Würzburg, Germany.; Neumann M; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Baldus CD; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Gökbuget N; Department of Medicine II, Goethe University, University Hospital, Frankfurt, Germany.; Brüggemann M; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Dreyling M; Department of Medicine, Medical Clinic III, Ludwig-Maximilian-University Hospital, Munich, Germany.; Fowler NH; The University of Texas MD Anderson Cancer Center, Houston, TX.; BostonGene, Waltham, MA.; Dickinson M; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Martinez-Lopez J; Hospital 12 De Octubre, Complutense University, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain.; Kolstad A; Oslo University Hospital, Oslo, Norway.; Butler J; Royal Brisbane Hospital, Herston, QLD, Australia.; Ghosh M; Division of Hematology/Oncology, Michigan Medicine University of Michigan, Ann Arbor, MI.; Popplewell L; City of Hope Comprehensive Cancer Center, Duarte, CA.; Chavez JC; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL.; Bachy E; Clinical Hematology, Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France.; Kato K; Department of Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Harigae H; Department of Hematology, Tohoku University Hospital, Sendai, Japan.; Kersten MJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands, on behalf of Stichting Hemato-Oncologie voor Volwassenen Nederland/Lunenburg Lymphoma Phase I/II Consortium.; Andreadis C; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.; Riedell PA; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.; Ho PJ; Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.; Pérez-Simón JA; Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla Consejo Superior de Investigaciones Cientificas, Universidad de Sevilla, Seville, Spain.; Chen AI; Oregon Health and Science University, Portland, OR.; Nastoupil LJ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; von Tresckow B; Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; María Ferreri AJ; Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Teshima T; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.; Patten PEM; Comprehensive Cancer Centre, King's College London, London, United Kingdom.; Department of Haematology, King's College Hospital, London, United Kingdom.; McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer l Center, Westwood, KS.; Petzer AL; Internal Medicine I, Ordensklinikum Linz Barmherzige Schwestern-Elisabethinen, Linz, Austria.; Offner F; Universitair Ziekenhuis Gent, Ghent, Belgium.; Viardot A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.; Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli,' Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.; Malladi R; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Paule I; Novartis Pharma AG, Basel, Switzerland.; Zia A; Novartis Pharma AG, Basel, Switzerland.; Awasthi R; Novartis Institutes for BioMedical Research, East Hanover, NJ.; Han X; Novartis Pharmaceuticals Corporation, East Hanover, NJ.; Germano D; Novartis Pharma AG, Basel, Switzerland.; O'Donovan D; Novartis Pharmaceuticals Corporation, Dublin, Ireland.; Ramos R; Novartis Pharmaceuticals Corporation, East Hanover, NJ.; Maier HJ; Novartis Pharma AG, Basel, Switzerland.; Masood A; Novartis Pharmaceuticals Corporation, East Hanover, NJ.; Thieblemont C; Service d'hémato-oncologie, Hôpital Saint-Louis, Paris, France.; Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Fuchs M; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Jacob AS; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Kaul H; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Kobe C; Department of Nuclear Medicine, University of Cologne, Cologne, Germany.; Kuhnert G; Nuclear Medicine Siegen I Kreuztal, Siegen, Germany.; Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.; Greil R; IIIrd Medical Department, Paracelcus Medical University and Salzburg Cancer Research Institute, Salzburg, Austria.; Salzburg Cancer Research Institute and AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie), Salzburg, Austria.; Bröckelmann PJ; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.; Just M; Dres. med. Just/Düwel/Riesenberg/Steinke/Schäfer, Studiengesellschaft, Bielefeld, Germany.; Hertenstein B; Department of Internal Medicine I, Klinikum Bremen Mitte, Bremen, Germany.; Soekler M; Onkology, Spital Thun, Switzerland, formerly University of Tübingen, Tübingen, Germany.; Vogelhuber M; Medizinische Klinik III, Universitätsklinik Regensburg, Regensburg, Germany.; Zijlstra JM; Department of Hematology, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands.; Keller UB; Department of Internal Medicine III, Klinikum 'Rechts der Isar', Munich, Germany.; Krause SW; Department of Internal Medicine 5, Haematology/Oncology, Uniklinikum Erlangen, Erlangen, Germany.; Dührsen U; Department of Haematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Meissner J; University of Heidelberg, Heidelberg, Germany.; Viardot A; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.; Eich HT; Department of Radiotherapy, University Hospital of Muenster, Muenster, Germany.; Baues C; Department of Radiotherapy, University of Cologne, Cologne, Germany.; Diehl V; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Rosenwald A; Institute of Pathology, Julius Maximilian University of Würzburg and Comprehensive Cancer Center Mainfranken, Würzburg, Germany.; Buehnen I; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; von Tresckow B; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Department of Haematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Dietlein M; Department of Nuclear Medicine, University of Cologne, Cologne, Germany.; Borchmann P; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Engert A; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Eichenauer DA; German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany. dennis.eichenauer@uk-koeln.de.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Hayes AG; Department of Diabetes and Endocrinology, St Vincent's Hospital, Sydney, Australia.; Raven LM; Department of Diabetes and Endocrinology, St Vincent's Hospital, Sydney, Australia.; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.; Viardot A; Department of Diabetes and Endocrinology, St Vincent's Hospital, Sydney, Australia.; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.; Kotlyar E; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.; Department of Heart and Lung Transplantation, St Vincent's Hospital, Sydney, Australia.; Victor Chang Cardiac Research Institute, Sydney, Australia.; Greenfield JR; Department of Diabetes and Endocrinology, St Vincent's Hospital, Sydney, Australia.; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.

Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE

Dreger P; Department of Medicine V, University of Heidelberg, Heidelberg, Germany. Electronic address: peter.dreger@med.uni-heidelberg.de.; Corradini P; Division of Hematology, IRCCS Istituto Nazionale dei Tumori Milano, University of Milano, Milan, Italy.; Gribben JG; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Glass B; Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany.; Jerkeman M; Department of Oncology, Skane University Hospital, Lund, Sweden.; Kersten MJ; Department of Hematology, Amsterdam UMC, location AMC, Cancer Center Amsterdam and LYMMCARE, Amsterdam, Netherlands.; Morschhauser F; Hematology Department, CHU Lille, Université de Lille, ULR 7365, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France.; Mussetti A; Hematology Department, Institut Català d'Oncologia - Hospitalet, Institut d'Investigació Biomèdique de Bellvitge, Universitat de Barcelona, Barcelona, Spain.; Viardot A; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.; Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.; Sureda A; Hematology Department, Institut Català d'Oncologia - Hospitalet, Institut d'Investigació Biomèdique de Bellvitge, Universitat de Barcelona, Barcelona, Spain.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

Welch S; St. Vincent's Hospital, 390 Victoria St., Darlinghurst 2010, Australia.; University of Sydney, School of Pharmacy, Faculty of Medicine and Health, Camperdown, Sydney, N.S.W 2006, Australia.; Moles R; University of Sydney, School of Pharmacy, Faculty of Medicine and Health, Camperdown, Sydney, N.S.W 2006, Australia.; Viardot A; St. Vincent's Hospital, 390 Victoria St., Darlinghurst 2010, Australia.; Garvan Institute, University of New South Wales, Randwick, Sydney, N.S.W. 2010, Australia.; Deweerd P; St. Vincent's Hospital, 390 Victoria St., Darlinghurst 2010, Australia.; Daly S; St. Vincent's Hospital, 390 Victoria St., Darlinghurst 2010, Australia.; Lee K; University of Sydney, Addiction Medicine, Faculty of Medicine and Health, Camperdown, Sydney 2006, Australia.; The Edith Collins Centre, Camperdown, Sydney, 2006, Australia.; Centre for Alcohol Policy Research, La Trobe University, Bundoora, Vic 3083, Australia.; Burnet Institute, Melbourne, Vic 3004, Australia.; National Drug Research Institute, Curtin University, Perth, WA, 6045, Australia.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918266300706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2667-2766 (Electronic) Linking ISSN: 26672766 NLM ISO Abbreviation: Explor Res Clin Soc Pharm Subsets: PubMed not MEDLINE